VanEck Associates’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-132
| Closed | -$17K | – | 1420 |
|
|
2025
Q3 | $17K | Sell |
132
-872
| -87% | -$112K | ﹤0.01% | 1378 |
|
|
2025
Q2 | $129K | Sell |
1,004
-112
| -10% | -$11.6K | ﹤0.01% | 1287 |
|
|
2025
Q1 | $99K | Hold |
1,116
| – | – | ﹤0.01% | 1281 |
|
|
2024
Q4 | $97K | Buy |
1,116
+363
| +48% | +$33.3K | ﹤0.01% | 1273 |
|
|
2024
Q3 | $64K | Sell |
753
-363
| -33% | -$36.1K | ﹤0.01% | 1267 |
|
|
2024
Q2 | $120K | Buy |
1,116
+131
| +13% | +$13.1K | ﹤0.01% | 1241 |
|
|
2024
Q1 | $93K | Buy |
985
+113
| +13% | +$9.69K | ﹤0.01% | 1238 |
|
|
2023
Q4 | $80K | Buy |
872
+193
| +28% | +$12.5K | ﹤0.01% | 1255 |
|
|
2023
Q3 | $34K | Hold |
679
| – | – | ﹤0.01% | 1308 |
|
|
2023
Q2 | $43K | Sell |
679
-146
| -18% | -$7.94K | ﹤0.01% | 1308 |
|
|
2023
Q1 | $37K | Sell |
825
-161
| -16% | -$7.25K | ﹤0.01% | 1323 |
|
|
2022
Q4 | $43K | Buy |
986
+334
| +51% | +$16K | ﹤0.01% | 1325 |
|
|
2022
Q3 | $43K | Buy |
+652
| New | +$41.9K | ﹤0.01% | 1276 |
|
|
2022
Q2 | – | Sell |
-1,548
| Closed | -$99K | – | 1379 |
|
|
2022
Q1 | $99K | Buy |
1,548
+213
| +16% | +$15.3K | ﹤0.01% | 1233 |
|
|
2021
Q4 | $143K | Buy |
1,335
+176
| +15% | +$18.4K | ﹤0.01% | 1177 |
|
|
2021
Q3 | $119K | Buy |
1,159
+431
| +59% | +$40.1K | ﹤0.01% | 1118 |
|
|
2021
Q2 | $64K | Buy |
728
+392
| +117% | +$35.9K | ﹤0.01% | 1170 |
|
|
2021
Q1 | $33K | Buy |
+336
| New | +$33.5K | ﹤0.01% | 1116 |
|
